ENdothelin-1 in inflammatory and malignant pleural effusions

Chi-Li Chung, Wei-Lin Chen, Shih-Hsin Hsiao, George Hsiao

研究成果: 雜誌貢獻會議摘要

摘要

SESSION TITLE: Pleural EffusionsSESSION TYPE: Original Investigation SlidePRESENTED ON: Tuesday, October 29, 2013 at 02:45 PM - 04:15 PMPURPOSE: Endothelin (ET)-1 can induce epithelial-mesenchymal transition (EMT) and has been shown implicated in tissue fibrosis and cancer metastases. However, the role of ET-1 in inflammatory and malignant pleural effusions has never been investigated. We aimed to determine whether ET-1 has a pathogenic role in exudative effusions and its clinical implication.METHODS: Pleural fluid ET-1 levels were measured in 108 consecutive patients presenting with undiagnosed pleural effusions and the levels were correlated with the etiology of effusions. Treatment outcome and pleural fibrosis, defined as radiological residual pleural thickening (RPT), were assessed at 6-month follow-up. Pleural mesothelial cells (PMCs) harvested from transudative pleural fluids were treated with or without (control) ET-1 (10 nM/ml), and the phenotypic changes and expression of EMT markers were assessed serially for 4 days.RESULTS: Exudative (n = 88) pleural effusions contained significantly higher ET-1 levels than transudative (n = 20) pleural effusions (median 2.55 vs. 1.82 pg/ml, P = 0.007). Median levels of ET-1 in both malignant (n = 32) and tuberculous (n = 36) effusions were significantly higher than those in parapneumonic (n = 20) effusions. The ET-1 levels in pleural fluids varied with different tumor histology. Among tuberculous effusions, 10 patients with RPT had significantly higher effusion ET-1 levels than did those without (P < 0.001). As compared to control, ET-1 time-dependently increased α-smooth muscle actin and decreased E-cadherin expression, and induced mesenchymal transformation of PMCs.CONCLUSIONS: ET-1 levels are raised in the majority of exudative effusions and are associated with tuberculous pleural fibrosis, implying a role for ET-1 in the pathogenesis of pleural effusion and fibrosis. The EMT effect of ET-1 on PMCs may indicate a biological activity of ET-1 on pleural tissue.CLINICAL IMPLICATIONS: Further studies are warranted to determine the clinical value of effusion ET-1 as a prognostic factor and a surrogate indicator of fibrogenesis in exudative pleural effusions.DISCLOSURE: The following authors have nothing to disclose: Chi-Li Chung, Wei-Lin Chen, Shih-Hsin Hsiao, George HsiaoNo Product/Research Disclosure Information
原文英語
頁(從 - 到)516A-516A
期刊Chest
144
發行號4_MeetingAbstracts
DOIs
出版狀態已發佈 - 十月 1 2013

指紋

Malignant Pleural Effusion
Endothelin-1
Pleural Effusion
Epithelial-Mesenchymal Transition
Fibrosis
Disclosure
Cadherins

引用此文

ENdothelin-1 in inflammatory and malignant pleural effusions. / Chung, Chi-Li; Chen, Wei-Lin; Hsiao, Shih-Hsin; Hsiao, George.

於: Chest, 卷 144, 編號 4_MeetingAbstracts, 01.10.2013, p. 516A-516A.

研究成果: 雜誌貢獻會議摘要

Chung, C-L, Chen, W-L, Hsiao, S-H & Hsiao, G 2013, 'ENdothelin-1 in inflammatory and malignant pleural effusions', Chest, 卷 144, 編號 4_MeetingAbstracts, 頁 516A-516A. https://doi.org/10.1378/chest.1701057
Chung, Chi-Li ; Chen, Wei-Lin ; Hsiao, Shih-Hsin ; Hsiao, George. / ENdothelin-1 in inflammatory and malignant pleural effusions. 於: Chest. 2013 ; 卷 144, 編號 4_MeetingAbstracts. 頁 516A-516A.
@article{dd0bb3a9053f4de79c86c70ce899e65a,
title = "ENdothelin-1 in inflammatory and malignant pleural effusions",
abstract = "SESSION TITLE: Pleural EffusionsSESSION TYPE: Original Investigation SlidePRESENTED ON: Tuesday, October 29, 2013 at 02:45 PM - 04:15 PMPURPOSE: Endothelin (ET)-1 can induce epithelial-mesenchymal transition (EMT) and has been shown implicated in tissue fibrosis and cancer metastases. However, the role of ET-1 in inflammatory and malignant pleural effusions has never been investigated. We aimed to determine whether ET-1 has a pathogenic role in exudative effusions and its clinical implication.METHODS: Pleural fluid ET-1 levels were measured in 108 consecutive patients presenting with undiagnosed pleural effusions and the levels were correlated with the etiology of effusions. Treatment outcome and pleural fibrosis, defined as radiological residual pleural thickening (RPT), were assessed at 6-month follow-up. Pleural mesothelial cells (PMCs) harvested from transudative pleural fluids were treated with or without (control) ET-1 (10 nM/ml), and the phenotypic changes and expression of EMT markers were assessed serially for 4 days.RESULTS: Exudative (n = 88) pleural effusions contained significantly higher ET-1 levels than transudative (n = 20) pleural effusions (median 2.55 vs. 1.82 pg/ml, P = 0.007). Median levels of ET-1 in both malignant (n = 32) and tuberculous (n = 36) effusions were significantly higher than those in parapneumonic (n = 20) effusions. The ET-1 levels in pleural fluids varied with different tumor histology. Among tuberculous effusions, 10 patients with RPT had significantly higher effusion ET-1 levels than did those without (P < 0.001). As compared to control, ET-1 time-dependently increased α-smooth muscle actin and decreased E-cadherin expression, and induced mesenchymal transformation of PMCs.CONCLUSIONS: ET-1 levels are raised in the majority of exudative effusions and are associated with tuberculous pleural fibrosis, implying a role for ET-1 in the pathogenesis of pleural effusion and fibrosis. The EMT effect of ET-1 on PMCs may indicate a biological activity of ET-1 on pleural tissue.CLINICAL IMPLICATIONS: Further studies are warranted to determine the clinical value of effusion ET-1 as a prognostic factor and a surrogate indicator of fibrogenesis in exudative pleural effusions.DISCLOSURE: The following authors have nothing to disclose: Chi-Li Chung, Wei-Lin Chen, Shih-Hsin Hsiao, George HsiaoNo Product/Research Disclosure Information",
author = "Chi-Li Chung and Wei-Lin Chen and Shih-Hsin Hsiao and George Hsiao",
note = "10.1378/chest.1701057",
year = "2013",
month = "10",
day = "1",
doi = "10.1378/chest.1701057",
language = "English",
volume = "144",
pages = "516A--516A",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "4_MeetingAbstracts",

}

TY - JOUR

T1 - ENdothelin-1 in inflammatory and malignant pleural effusions

AU - Chung, Chi-Li

AU - Chen, Wei-Lin

AU - Hsiao, Shih-Hsin

AU - Hsiao, George

N1 - 10.1378/chest.1701057

PY - 2013/10/1

Y1 - 2013/10/1

N2 - SESSION TITLE: Pleural EffusionsSESSION TYPE: Original Investigation SlidePRESENTED ON: Tuesday, October 29, 2013 at 02:45 PM - 04:15 PMPURPOSE: Endothelin (ET)-1 can induce epithelial-mesenchymal transition (EMT) and has been shown implicated in tissue fibrosis and cancer metastases. However, the role of ET-1 in inflammatory and malignant pleural effusions has never been investigated. We aimed to determine whether ET-1 has a pathogenic role in exudative effusions and its clinical implication.METHODS: Pleural fluid ET-1 levels were measured in 108 consecutive patients presenting with undiagnosed pleural effusions and the levels were correlated with the etiology of effusions. Treatment outcome and pleural fibrosis, defined as radiological residual pleural thickening (RPT), were assessed at 6-month follow-up. Pleural mesothelial cells (PMCs) harvested from transudative pleural fluids were treated with or without (control) ET-1 (10 nM/ml), and the phenotypic changes and expression of EMT markers were assessed serially for 4 days.RESULTS: Exudative (n = 88) pleural effusions contained significantly higher ET-1 levels than transudative (n = 20) pleural effusions (median 2.55 vs. 1.82 pg/ml, P = 0.007). Median levels of ET-1 in both malignant (n = 32) and tuberculous (n = 36) effusions were significantly higher than those in parapneumonic (n = 20) effusions. The ET-1 levels in pleural fluids varied with different tumor histology. Among tuberculous effusions, 10 patients with RPT had significantly higher effusion ET-1 levels than did those without (P < 0.001). As compared to control, ET-1 time-dependently increased α-smooth muscle actin and decreased E-cadherin expression, and induced mesenchymal transformation of PMCs.CONCLUSIONS: ET-1 levels are raised in the majority of exudative effusions and are associated with tuberculous pleural fibrosis, implying a role for ET-1 in the pathogenesis of pleural effusion and fibrosis. The EMT effect of ET-1 on PMCs may indicate a biological activity of ET-1 on pleural tissue.CLINICAL IMPLICATIONS: Further studies are warranted to determine the clinical value of effusion ET-1 as a prognostic factor and a surrogate indicator of fibrogenesis in exudative pleural effusions.DISCLOSURE: The following authors have nothing to disclose: Chi-Li Chung, Wei-Lin Chen, Shih-Hsin Hsiao, George HsiaoNo Product/Research Disclosure Information

AB - SESSION TITLE: Pleural EffusionsSESSION TYPE: Original Investigation SlidePRESENTED ON: Tuesday, October 29, 2013 at 02:45 PM - 04:15 PMPURPOSE: Endothelin (ET)-1 can induce epithelial-mesenchymal transition (EMT) and has been shown implicated in tissue fibrosis and cancer metastases. However, the role of ET-1 in inflammatory and malignant pleural effusions has never been investigated. We aimed to determine whether ET-1 has a pathogenic role in exudative effusions and its clinical implication.METHODS: Pleural fluid ET-1 levels were measured in 108 consecutive patients presenting with undiagnosed pleural effusions and the levels were correlated with the etiology of effusions. Treatment outcome and pleural fibrosis, defined as radiological residual pleural thickening (RPT), were assessed at 6-month follow-up. Pleural mesothelial cells (PMCs) harvested from transudative pleural fluids were treated with or without (control) ET-1 (10 nM/ml), and the phenotypic changes and expression of EMT markers were assessed serially for 4 days.RESULTS: Exudative (n = 88) pleural effusions contained significantly higher ET-1 levels than transudative (n = 20) pleural effusions (median 2.55 vs. 1.82 pg/ml, P = 0.007). Median levels of ET-1 in both malignant (n = 32) and tuberculous (n = 36) effusions were significantly higher than those in parapneumonic (n = 20) effusions. The ET-1 levels in pleural fluids varied with different tumor histology. Among tuberculous effusions, 10 patients with RPT had significantly higher effusion ET-1 levels than did those without (P < 0.001). As compared to control, ET-1 time-dependently increased α-smooth muscle actin and decreased E-cadherin expression, and induced mesenchymal transformation of PMCs.CONCLUSIONS: ET-1 levels are raised in the majority of exudative effusions and are associated with tuberculous pleural fibrosis, implying a role for ET-1 in the pathogenesis of pleural effusion and fibrosis. The EMT effect of ET-1 on PMCs may indicate a biological activity of ET-1 on pleural tissue.CLINICAL IMPLICATIONS: Further studies are warranted to determine the clinical value of effusion ET-1 as a prognostic factor and a surrogate indicator of fibrogenesis in exudative pleural effusions.DISCLOSURE: The following authors have nothing to disclose: Chi-Li Chung, Wei-Lin Chen, Shih-Hsin Hsiao, George HsiaoNo Product/Research Disclosure Information

UR - http://ac.els-cdn.com/S0012369216431508/1-s2.0-S0012369216431508-main.pdf?_tid=45b0ae3a-4fe4-11e6-8d31-00000aab0f27&acdnat=1469175432_e5181167b45acdb53e3be49b5b987b5a

U2 - 10.1378/chest.1701057

DO - 10.1378/chest.1701057

M3 - Meeting Abstract

VL - 144

SP - 516A-516A

JO - Chest

JF - Chest

SN - 0012-3692

IS - 4_MeetingAbstracts

ER -